Senazodan

Modify Date: 2024-02-04 15:42:21

Senazodan Structure
Senazodan structure
Common Name Senazodan
CAS Number 98326-32-0 Molecular Weight 266.29800
Density 1.3g/cm3 Boiling Point N/A
Molecular Formula C15H14N4O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Senazodan


Senazodan is a Ca2+ sensitiser, and also shows inhibition effect on PDE III.

 Names

Name 3-[4-(pyridin-4-ylamino)phenyl]-4,5-dihydro-1H-pyridazin-6-one
Synonym More Synonyms

 Senazodan Biological Activity

Description Senazodan is a Ca2+ sensitiser, and also shows inhibition effect on PDE III.
Related Catalog
In Vitro Senazodan seems to affect directly the actin-myosin crossbridge kinetics, and increase myosin ATPase activity[1]. Senazodan produces a concentration-dependent increase in tension development. Senazodan enhance Ca2+ binding to myofilaments and to purified cardiac troponin C. Senazodan also enhances contractility in guinea-pig papillary muscles by inhibiting PDE III[2].
References

[1]. Lehtonen LA, et al. Pharmacokinetics and pharmacodynamics of intravenous inotropic agents. Clin Pharmacokinet. 2004;43(3):187-203.

[2]. Erhardt L. An emerging role for calcium sensitisation in the treatment of heart failure. Expert Opin Investig Drugs. 2005 Jun;14(6):659-70.

 Chemical & Physical Properties

Density 1.3g/cm3
Molecular Formula C15H14N4O
Molecular Weight 266.29800
Exact Mass 266.11700
PSA 73.10000
LogP 1.57270
Index of Refraction 1.677

 Synonyms

Senazodan
6-[4-(pyridin-4-ylamino)phenyl]-4,5-dihydropyridazin-3(2h)-one
3(2H)-Pyridazinone,4,5-dihydro-6-(4-(4-pyridinylamino)phenyl)
6-(4-(4-Pyridinylamino)phenyl)-4,5-dihydro-3(2H)-pyridazinone
UNII-427L2I2KIM